Buy, Sell or Hold: ImmunityBio (UBRX-Q)

Home

Daily Stock Opinions and Ratings

ImmunityBio (UBRX-Q)

0.00

0.00 (0.00%) 1d

Nervous markets await Nvidia

DON'T BUY

They have been losing money a long time.

Showing 1 to 1 of 1 entries

ImmunityBio(UBRX-Q) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 1

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 3

Stockchase rating for ImmunityBio is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

ImmunityBio(UBRX-Q) Frequently Asked Questions

What is ImmunityBio stock symbol?

ImmunityBio is a OTC stock, trading under the symbol UBRX-Q on the (). It is usually referred to as or UBRX-Q

Is ImmunityBio a buy or a sell?

In the last year, 3 stock analysts published opinions about UBRX-Q. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for ImmunityBio.

Is ImmunityBio a good investment or a top pick?

ImmunityBio was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for ImmunityBio.

Why is ImmunityBio stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is ImmunityBio worth watching?

In the last year, there was no coverage of ImmunityBio published on Stockchase.

What is ImmunityBio stock price?

On , ImmunityBio (UBRX-Q) stock closed at a price of $.

Most Recent Experts

Eric Nuttall

Ninepoint Partners

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Jim Cramer - Mad Money

CNBC

Darren Sissons

Campbell Lee & Ross

Stockchase Insights

5i Research

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.